Enginzyme Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.78M

  • Investors
  • 14

Enginzyme General Information

Description

Developer of enzyme immobilization technology designed to provide sustainable manufacturing solutions for the personal care, food, and pharmaceutical industries. The company provides engineering and deployment services for biocatalytic processes, enabling manufacturers to reduce production costs, improve product quality, and transition to clean manufacturing practices.

Contact Information

Website
www.enginzyme.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tomtebodavägen 6
  • 171 65 Solna
  • Sweden
Primary Industry
Specialty Chemicals
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Climate Tech
Corporate Office
  • Tomtebodavägen 6
  • 171 65 Solna
  • Sweden

Enginzyme Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enginzyme Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 23-Sep-2026 $7.78M Completed Generating Revenue
5. Accelerator/Incubator 04-Sep-2024 Completed Generating Revenue
4. Later Stage VC (Series B) 19-Dec-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Jun-2021 Completed Generating Revenue
2. Later Stage VC (Series A) 11-Feb-2021 $13M $16.9M Completed Generating Revenue
1. Angel (individual) $3.93M $3.93M Completed Startup
To view Enginzyme’s complete valuation and funding history, request access »

Enginzyme Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 4,402 $212.74 $212.74 1x $212.74 2.72%
Ordinary 5,617 $152.39 $152.39 1x $152.39 3.47%
To view Enginzyme’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Enginzyme Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of enzyme immobilization technology designed to provide sustainable manufacturing solutions for the personal c
Specialty Chemicals
Solna, Sweden
30 As of 2026

London, United Kingdom
 

Lyngby, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enginzyme Competitors (4)

One of Enginzyme’s 4 competitors is FabricNano, a Venture Capital-Backed company based in London, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
FabricNano Venture Capital-Backed London, United Kingdom
Novonesis Corporation Lyngby, Denmark
Debut Biotechnology Venture Capital-Backed San Diego, CA
Codexis Formerly VC-backed Redwood City, CA
To view Enginzyme’s complete competitors history, request access »

Enginzyme Patents

  • 34

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

Enginzyme Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026057620-A1 Enzymatic process for the production of n1-methylpseudouridine 5'-triphosphate Pending 10-Sep-2024
US-20250361534-A1 Batch process for enzymatic modification of lipids Pending 27-May-2022
WO-2023229519-A1 Batch process for enzymatic modification of lipids Inactive 27-May-2022
AU-2023274453-A1 Biocatalysts for organic synthesis Pending 27-May-2022
EP-4532708-A1 Biocatalysts for organic synthesis Pending 27-May-2022 C12N11/14
To view Enginzyme’s complete patent history, request access »

Enginzyme Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enginzyme Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lotus Singapore Group Family Office Minority
Stiftelsen Industrifonden Venture Capital Minority
Valquest Partners Asset Manager Minority
Mondelez International Corporation
Almi Invest Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Enginzyme FAQs

  • When was Enginzyme founded?

    Enginzyme was founded in 2014.

  • Where is Enginzyme headquartered?

    Enginzyme is headquartered in Solna, Sweden.

  • What is the size of Enginzyme?

    Enginzyme has 30 total employees.

  • What industry is Enginzyme in?

    Enginzyme’s primary industry is Specialty Chemicals.

  • Is Enginzyme a private or public company?

    Enginzyme is a Private company.

  • What is Enginzyme’s current revenue?

    The current revenue for Enginzyme is .

  • How much funding has Enginzyme raised over time?

    Enginzyme has raised $53.5M.

  • Who are Enginzyme’s investors?

    Lotus Singapore Group, Stiftelsen Industrifonden, Valquest Partners, Mondelez International, and Almi Invest are 5 of 14 investors who have invested in Enginzyme.

  • Who are Enginzyme’s competitors?

    FabricNano, Novonesis, Debut Biotechnology, and Codexis are competitors of Enginzyme.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process